Contineum Therapeutics has pumped the brakes on two projects, freeing up resources to go full speed ahead in its pursuit of Bristol Myers Squibb in idiopathic pulmonary fibrosis (IPF). The San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback